Data as of Mar 07
| -0.03 / -1.97%|
Cadus Corp. engages in development and application of novel yeast-based and other drug discovery technologies. It changed its name to Cadus Corp. from Cadus Pharmaceutical Corp. The company has developed technologies based on yeast that are useful in identifying drug discovery candidates and also proprietary technology to insert human genes into yeast cells to create hybrid yeast cells. Cadus was founded on January 23, 1992 and is headquartered in New York, NY.
|David Blitz||President, CEO, CFO, Secretary & Treasurer|
|James R. Broach||Director & Research Director|